Medicilon Passes FDA Inspection, Reinforcing Global R&D Excellence
On May 20, Medicilon Preclinical Research (Shanghai) LLC (“Medicilon”) announces that it has successfully passed an on-site inspection by the FDA. The company receives an official Establishment Inspection Report (EIR)...

